No Data
No Data
gtja: Bullish on innovative drugs policy, expected to continue to advance. Chinese patent medicine centralized procurement may face accelerated expansion.
With the support of the entire chain, innovative drugs have seen a series of bullish policies introduced in various regions, and favorable policies are expected to continue to advance in the future; centralized procurement of chinese patent medicine may accelerate its expansion.
Goldman Sachs Raises China Economic Growth Forecasts
BOCOM Intl: Short-term pharmaceutical sector still has some room for recovery, focusing on recommending Simcere Pharma (02096) and others.
bocom intl key recommended simcere pharma (02096), hutchmed (china) (00013), connoah-b (02162) and akeso (09926), etc.
China's Stocks Lose Steam as Enthusiasm for Major Stimulus Wanes. What's Next?
Shares of US-listed Chinese Stocks Are Trading Higher as the Sector Rebounds Following Thursday's Selloff. Strength May Be Due to the Recent Stimulus Package and the Golden Week Holidays.
Express News | Shares of US-listed Chinese Stocks Are Trading Higher as the Sector Rebounds Following Thursday's Selloff. Strength May Be Due to the Recent Stimulus Package and the Golden Week Holidays
No Data
No Data